Janney Capital Management LLC lessened its position in Masimo Co. (NASDAQ:MASI) by 1.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,167 shares of the medical equipment provider’s stock after selling 88 shares during the quarter. Janney Capital Management LLC’s holdings in Masimo were worth $714,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in MASI. Meeder Asset Management Inc. grew its holdings in Masimo by 20.9% in the 4th quarter. Meeder Asset Management Inc. now owns 9,071 shares of the medical equipment provider’s stock valued at $973,000 after buying an additional 1,569 shares during the last quarter. Piedmont Investment Advisors Inc. lifted its position in shares of Masimo by 41.9% during the 4th quarter. Piedmont Investment Advisors Inc. now owns 4,631 shares of the medical equipment provider’s stock worth $497,000 after buying an additional 1,368 shares during the period. Round Table Services LLC bought a new position in shares of Masimo during the 1st quarter worth approximately $221,000. Fundsmith LLP bought a new position in shares of Masimo during the 4th quarter worth approximately $51,470,000. Finally, First Hawaiian Bank lifted its position in shares of Masimo by 170.0% during the 4th quarter. First Hawaiian Bank now owns 1,080 shares of the medical equipment provider’s stock worth $116,000 after buying an additional 680 shares during the period. Hedge funds and other institutional investors own 81.02% of the company’s stock.
In other news, CAO Ramshorst David J. Van sold 1,845 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $140.00, for a total value of $258,300.00. Following the completion of the sale, the chief accounting officer now directly owns 1,695 shares of the company’s stock, valued at $237,300. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $135.00, for a total transaction of $1,350,000.00. Following the transaction, the director now directly owns 74,832 shares of the company’s stock, valued at $10,102,320. The disclosure for this sale can be found here. Insiders have sold a total of 45,572 shares of company stock valued at $6,300,560 over the last ninety days. 11.50% of the stock is currently owned by insiders.
MASI has been the subject of several analyst reports. BidaskClub upgraded Masimo from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 14th. BTIG Research cut Masimo from a “buy” rating to a “neutral” rating and set a $134.50 target price for the company. in a research note on Tuesday, April 16th. Needham & Company LLC reaffirmed a “buy” rating and set a $158.00 price objective (up from $155.00) on shares of Masimo in a research note on Tuesday, May 7th. UBS Group lifted their target price on Masimo from $147.00 to $160.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Finally, Piper Jaffray Companies reiterated an “overweight” rating and set a $140.00 target price on shares of Masimo in a report on Wednesday, February 27th. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Masimo has an average rating of “Buy” and a consensus price target of $154.25.
Masimo stock traded up $1.25 during trading hours on Friday, reaching $138.97. 213,775 shares of the company’s stock were exchanged, compared to its average volume of 451,136. Masimo Co. has a twelve month low of $96.14 and a twelve month high of $147.91. The company has a market cap of $7.38 billion, a P/E ratio of 45.86, a PEG ratio of 2.77 and a beta of 1.12.
Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Monday, May 6th. The medical equipment provider reported $0.79 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.75 by $0.04. The company had revenue of $231.70 million during the quarter, compared to analyst estimates of $223.67 million. Masimo had a net margin of 22.49% and a return on equity of 18.61%. Masimo’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.75 EPS. Analysts forecast that Masimo Co. will post 3.12 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Janney Capital Management LLC Has $714,000 Position in Masimo Co. (NASDAQ:MASI)” was first published by Sundance Herald and is the sole property of of Sundance Herald. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://sundanceherald.com/2019/05/24/masimo-co-masi-holdings-reduced-by-janney-capital-management-llc.html.
Masimo Company Profile
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
See Also: NASDAQ
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.